FRACTYL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.44 USD | -0.67% |
|
+3.98% | 0.00% |
| Jul. 01 | Fractyl Health, Inc.(NasdaqGM:GUTS) added to Russell Small Cap Comp Value Index | CI |
| Jul. 01 | Fractyl Health, Inc.(NasdaqGM:GUTS) added to Russell Small Cap Completeness Index | CI |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 212.7 | - | - |
| Enterprise Value (EV) 1 | 437.6 | 375.4 | 392.8 |
| P/E ratio | -2.05 x | -2 x | - |
| Yield | - | - | - |
| Capitalization / Revenue | 6,444 x | - | 31.7 x |
| EV / Revenue | 13,259 x | - | 58.5 x |
| EV / EBITDA | -5.29 x | -3.15 x | -2.13 x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Price to Book | -0.71 x | -0.96 x | -1.14 x |
| Nbr of stocks (in thousands) | 47,897 | - | - |
| Reference price 2 | 4.440 | 4.440 | 4.440 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 0.12 | 0.033 | - | 6.717 |
| EBITDA 1 | - | -50.55 | -82.76 | -119.2 | -184.6 |
| EBIT 1 | - | -50.84 | -83.35 | -109.9 | -167.5 |
| Operating Margin | - | -42,363.33% | -252,575.12% | - | -2,493.55% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income 1 | -46.45 | -94.27 | -81.99 | -119 | - |
| Net margin | - | -78,559.17% | -248,442.42% | - | - |
| EPS 2 | -14.90 | - | -2.170 | -2.220 | - |
| Free Cash Flow | - | - | - | - | - |
| FCF margin | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 8/22/23 | 4/1/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 |
|---|---|
| Net sales 1 | 0.033 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | -3.322 |
| Net margin | -10,066.67% |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | 5/13/24 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | 225 | 163 | 180 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -2.718 x | -1.366 x | -0.9758 x |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share 2 | - | - | -6.290 | -4.630 | -3.880 |
| Cash Flow per Share 2 | - | - | -1.850 | -2.010 | - |
| Capex | - | - | - | - | - |
| Capex / Sales | - | - | - | - | - |
| Announcement Date | 8/22/23 | 4/1/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.44
USD
Average target price
20
USD
Spread / Average Target
+350.45%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 213M | |
| +16.61% | 122B | |
| +17.75% | 112B | |
| +17.23% | 25.91B | |
| -24.11% | 19.33B | |
| -18.56% | 16.17B | |
| -18.47% | 15.6B | |
| -47.75% | 14.65B | |
| +57.35% | 14.34B | |
| +5.62% | 14B |
- Stock Market
- Equities
- GUTS Stock
- Financials Fractyl Health, Inc.
